Literature DB >> 24213474

Life history trade-offs in cancer evolution.

C Athena Aktipis1, Amy M Boddy, Robert A Gatenby, Joel S Brown, Carlo C Maley.   

Abstract

Somatic evolution during cancer progression and therapy results in tumour cells that show a wide range of phenotypes, which include rapid proliferation and quiescence. Evolutionary life history theory may help us to understand the diversity of these phenotypes. Fast life history organisms reproduce rapidly, whereas those with slow life histories show less fecundity and invest more resources in survival. Life history theory also provides an evolutionary framework for phenotypic plasticity, which has potential implications for understanding 'cancer stem cells'. Life history theory suggests that different therapy dosing schedules might select for fast or slow life history cell phenotypes, with important clinical consequences.

Entities:  

Mesh:

Year:  2013        PMID: 24213474      PMCID: PMC4010142          DOI: 10.1038/nrc3606

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  85 in total

1.  Cost of reproduction, resource quality, and terminal investment in a burying beetle.

Authors:  J Curtis Creighton; Nicholas D Heflin; Mark C Belk
Journal:  Am Nat       Date:  2009-11       Impact factor: 3.926

2.  Resource competition and within-host disease dynamics.

Authors:  V H Smith; R D Holt
Journal:  Trends Ecol Evol       Date:  1996-09       Impact factor: 17.712

3.  MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

Authors:  Jakub Godlewski; Michal O Nowicki; Agnieszka Bronisz; Gerard Nuovo; Jeff Palatini; Michael De Lay; James Van Brocklyn; Michael C Ostrowski; E Antonio Chiocca; Sean E Lawler
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

Review 4.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

Review 5.  Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.

Authors:  Roel H Wilting; Jan-Hermen Dannenberg
Journal:  Drug Resist Updat       Date:  2012-02-20       Impact factor: 18.500

6.  Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.

Authors:  Massimiliano Mazzone; Daniela Dettori; Rodrigo Leite de Oliveira; Sonja Loges; Thomas Schmidt; Bart Jonckx; Ya-Min Tian; Anthony A Lanahan; Patrick Pollard; Carmen Ruiz de Almodovar; Frederik De Smet; Stefan Vinckier; Julián Aragonés; Koen Debackere; Aernout Luttun; Sabine Wyns; Benedicte Jordan; Alberto Pisacane; Bernard Gallez; Maria Grazia Lampugnani; Elisabetta Dejana; Michael Simons; Peter Ratcliffe; Patrick Maxwell; Peter Carmeliet
Journal:  Cell       Date:  2009-02-12       Impact factor: 41.582

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  A comparison of cortical proteins in Tetrahymena vorax microstomes and macrostomes.

Authors:  H E Buhse; N E Williams
Journal:  J Protozool       Date:  1982-05

Review 9.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

Review 10.  Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

Authors:  Piet Borst
Journal:  Open Biol       Date:  2012-05       Impact factor: 6.411

View more
  78 in total

1.  Ancient hot and cold genes and chemotherapy resistance emergence.

Authors:  Amy Wu; Qiucen Zhang; Guillaume Lambert; Zayar Khin; Robert A Gatenby; Hyunsung John Kim; Nader Pourmand; Kimberly Bussey; Paul C W Davies; James C Sturm; Robert H Austin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

Review 2.  Can oncology recapitulate paleontology? Lessons from species extinctions.

Authors:  Viola Walther; Crispin T Hiley; Darryl Shibata; Charles Swanton; Paul E Turner; Carlo C Maley
Journal:  Nat Rev Clin Oncol       Date:  2015-02-17       Impact factor: 66.675

3.  Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.

Authors:  Hongyi Zhang; Yulan Deng; Yong Zhang; Yanyan Ping; Hongying Zhao; Lin Pang; Xinxin Zhang; Li Wang; Chaohan Xu; Yun Xiao; Xia Li
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

Review 4.  Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming.

Authors:  Custodia García-Jiménez; Colin R Goding
Journal:  Cell Metab       Date:  2018-12-20       Impact factor: 27.287

5.  Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors.

Authors:  Anna S Trigos; Richard B Pearson; Anthony T Papenfuss; David L Goode
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

Review 6.  Changing mutational and adaptive landscapes and the genesis of cancer.

Authors:  L Alexander Liggett; James DeGregori
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-04       Impact factor: 10.680

Review 7.  Tumour heterogeneity and the evolutionary trade-offs of cancer.

Authors:  Jean Hausser; Uri Alon
Journal:  Nat Rev Cancer       Date:  2020-02-24       Impact factor: 60.716

8.  Game theory in the death galaxy: interaction of cancer and stromal cells in tumour microenvironment.

Authors:  Amy Wu; David Liao; Thea D Tlsty; James C Sturm; Robert H Austin
Journal:  Interface Focus       Date:  2014-08-06       Impact factor: 3.906

9.  Peto's paradox and the promise of comparative oncology.

Authors:  Leonard Nunney; Carlo C Maley; Matthew Breen; Michael E Hochberg; Joshua D Schiffman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

10.  Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies.

Authors:  Jill A Gallaher; Pedro M Enriquez-Navas; Kimberly A Luddy; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2018-01-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.